The American Lung Association recognizes that influencing public policy—through legislation and regulation—at all levels of government is key to achieving its mission: To save lives by improving lung health and preventing lung disease. 

The American Lung Association policy and advocacy program seeks to change government, corporate and community policies to help translate its mission into reality. The Public Policy Agenda for the 119th Congress identifies major legislative and regulatory issues on which the American Lung Association will take a leadership role to defend and advance the interests of public health. These represent opportunities for the American Lung Association to heighten public awareness, stimulate dialogue and change public policy on issues critical to its mission. 

Based on the American Lung Association Public Policy Positions, the Public Policy Agenda is designed to highlight the top priorities for the American Lung Association's federal advocacy efforts.   In addition, the American Lung Association engages robust public policy advocacy at the state and local level.   

Public Policy Agenda 119th Congress (2025-2026)

The public policy priorities for the 119th Congress are: 

• Support and defend investments and policies that eliminate health disparities caused by systemic racism; and build health equity across all policy areas;  
• Support and defend funding for research, prevention, diagnosis, interventions, treatment and cures for all lung diseases, including asthma, COPD, COVID-19, influenza, lung cancer, pulmonary fibrosis, and tuberculosis;  
• Support and defend funding for lung-related behavioral and environmental research and research training;  
• Support and defend funding for lung disease surveillance, prevention and wellness, public health infrastructure, and health programs related to the lung;  
• Defend investments in our nation’s public health infrastructure to address future public health emergencies especially in underserved communities, including data collection and surveillance mechanisms, sufficient personal protective equipment (PPE), and a trained and fully equipped public health workforce. 
• Support, protect and increase coverage and access to guidelines-based lung cancer screening;  
• Increase access to and availability of appropriate stationary and portable oxygen systems and quantities to ensure that patients who require supplemental oxygen, including liquid oxygen, have both their clinical and quality of life needs met;  
• Protect and defend barrier-free access to healthcare, including continued financial assistance to access coverage, coverage of essential health benefits,        no exclusions for pre-existing conditions  and no lifetime caps on health insurance.  
• Support and defend universal access to quality health care services including protecting Medicaid and Medicaid expansion, preventive services and immunizations; and ensuring access to appropriate specialty care, patient education and chronic disease management; coverage must be consistent with evidence-based guidelines.  
• Defend and implement the Clean Air Act and its protections, including the health-based National Ambient Air Quality Standards, to protect the health of all, including populations most at risk;  
• Increase air monitoring and reduce air pollution from mobile, stationary and area sources, including cars, trucks and diesel engines, oil and gas extraction and refining, power plants, and industry; promote zero-emission technologies  
• Defend federal policies and funding that protect lung health from the impacts of a changing climate;  
• Support and defend federal incentives for and investments in the research, development and demonstration of technologies that reduce public health and climate impacts from the transportation and energy sectors, including fewer lifecycle emissions of air pollutants, with a priority placed on zero-emission technologies;
• Support common-sense efforts to mitigate catastrophic wildfires, including through the use of appropriate prescribed burning tactics.  
• Support and defend initiatives and funding to improve indoor air quality and reduce and mitigate exposure to radon in homes, schools and workplaces;  
• Promote and defend U.S. Food and Drug Administration regulatory authority and action over the manufacture, sale, distribution, labeling, marketing and promotion of all tobacco products including e-cigarettes and cigars.
• Defend funding for tobacco control programs, including prevention, education and cessation; and  
• Support and defend comprehensive coverage for tobacco cessation services under Medicaid, Medicare and both public and private insurance, and support health systems change to incorporate tobacco cessation.